Stephen M. Eggan, Ph.D.
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Schizophrenia; structure, function and development of prefrontal cortex; effects of cannabis and psychotropic medications on neural circuitryGoogle:
"Stephen Eggan"Mean distance: 15.84 (cluster 17) | S | N | B | C | P |
Parents
Sign in to add mentorDavid A. Lewis | grad student | 2007 | University of Pittsburgh | |
(Cannabinoid CB1 receptor: Role in primate prefrontal circuitry and schizophrenia.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Volk DW, Eggan SM, Horti AG, et al. (2014) Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia. Schizophrenia Research. 159: 124-9 |
Curley AA, Eggan SM, Lazarus MS, et al. (2013) Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia. Neurobiology of Disease. 50: 179-86 |
Eggan SM, Lazarus MS, Stoyak SR, et al. (2012) Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia. Biological Psychiatry. 71: 114-9 |
Volk DW, Eggan SM, Lewis DA. (2010) Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. The American Journal of Psychiatry. 167: 1489-98 |
Eggan SM, Stoyak SR, Verrico CD, et al. (2010) Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2060-71 |
Eggan SM, Melchitzky DS, Sesack SR, et al. (2010) Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex. Neuroscience. 169: 1651-61 |
Eggan SM, Mizoguchi Y, Stoyak SR, et al. (2010) Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex. Cerebral Cortex (New York, N.Y. : 1991). 20: 1164-74 |
Eggan SM, Hashimoto T, Lewis DA. (2008) Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Archives of General Psychiatry. 65: 772-84 |
Eggan SM, Lewis DA. (2007) Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cerebral Cortex (New York, N.Y. : 1991). 17: 175-91 |
Melchitzky DS, Eggan SM, Lewis DA. (2005) Synaptic targets of calretinin-containing axon terminals in macaque monkey prefrontal cortex. Neuroscience. 130: 185-95 |